The BRCA2 tumor suppressor protein is involved in the maintenance of genome integrity through its role in homologous recombination. In mitosis, BRCA2 is phosphorylated by Pololike kinase 1 (PLK1). Here we describe how this phosphorylation contributes to the control of mitosis. We identified two highly conserved phosphorylation sites at S193 and T207 of BRCA2. Phosphorylated-T207 is a bona fide docking site for PLK1 as illustrated by the crystal structure of the BRCA2 peptide bound to PLK1 Polo-box domain. We found that BRCA2 bound to PLK1 forms a complex with the phosphatase PP2A and phosphorylated-BUBR1. Reducing BRCA2 binding to PLK1, as observed in BRCA2 breast cancer variants S206C and T207A, alters the tetrameric complex resulting in misaligned chromosomes, faulty chromosome segregation and aneuploidy. We thus reveal a direct role of BRCA2 in the alignment of chromosomes, distinct from its DNA repair function, with important consequences on chromosome stability. These findings may explain in part the aneuploidy observed in BRCA2-mutated tumors.
Introduction
The BRCA2 tumor suppressor protein plays an important role in DNA repair by homologous 4 recombination (HR) 1, 2 that takes place preferentially during S/G2 phases of the cell cycle 3 .
5
BRCA2 has also emerging functions in mitosis, for example, at the kinetochore, it forms a 6 complex with BUBR1 4, 5 , an essential factor for the faithful segregation of chromosomes that 7 is required for kinetochore-microtubule attachment and is a component of the spindle 8 assembly checkpoint (SAC) 6, 7 . These two activities of BUBR1 involve different partners and 9 are functionally distinct 8, 9 . BRCA2 has been proposed to contribute to BUBR1 SAC activity 10 through direct binding and promoting its acetylation by the acetyl transferase PCAF 4, 10 ,
11
although due to confounding results in the BUBR1 interaction site in BRCA2, it is unclear if 12 this interaction is direct 4, 5 . At the end of mitosis, BRCA2 localizes to the midbody and assists 13 cell division by serving as a scaffold protein for the central spindle components [11] [12] [13] . In phosphorylated at the Kinetochore Attachment and Regulatory Domain (KARD) motif 27 (including residues S670, S676 and T680) 20 . Thus, the interplay between PLK1, BUBR1,
28
Aurora B and PP2A is necessary for the formation of stable kinetochore-microtubule 29 attachments.
30
PLK1 is recruited to specific targets via its Polo-box domain (PBD) 23 . PBD interacts with 31 phosphosites characterized by the consensus motif S-[pS/pT]-P/X 24 . These phosphosites are 32 provided by a priming phosphorylation event, usually mediated by CDK1 or other proline-33 directed kinases 17 ; however, there is also evidence that PLK1 itself might create docking sites
34
("self-priming") during cytokinesis 25, 26 .
35
Several BRCA2 sites have been suggested as phosphorylated by PLK1 in mitosis, some of 36 which belong to a cluster of serines and threonines located in BRCA2 N-terminus around 37 residue S193 14 . We set out to investigate which of these sites are phosphorylated by PLK1,
38
and to reveal whether these phosphorylation events play a role in the regulation of mitotic 39 progression. Here, we demonstrate that S193 and T207 are the only two residues that can be 40 phosphorylated by PLK1 in the conserved region around S193, and we further reveal that 41 phosphorylated BRCA2-T207 is a bona fide docking site for PLK1. By investigating the 42 phenotype of BRCA2 missense variants that limit the phosphorylation of BRCA2-T207, we to counter excessive Aurora B activity at the kinetochores 20 . A defect in this function of
BRCA2-T207 is a target of phosphorylation by PLK1

77
The reduction of BRCA2 phosphorylation in BRCA2 containing T207A and S206C
78
variants suggested that these residues could be targets for PLK1 phosphorylation. We and BRCA2 190-284 before (black) and after (red) phosphorylation with recombinant PLK1.
87
Analysis of these experiments revealed phosphorylation of S193 and of three other phosphorylates significantly less BRCA2 containing the variant T207A than the WT 100 peptide (Fig. 2c) . The initial phosphorylation rate of S193 was decreased by a factor of 2 (Fig.
101
To provide further evidence that the PLK1-mediated phosphorylation of BRCA2 favors 127 BRCA2 binding, we performed an in vitro kinase assay with recombinant proteins followed
128
by an amylose pull-down and eluted the bound proteins with maltose. PLK1 was found in the 129 maltose elution with BRCA2 1-250 -WT demonstrating that PLK1-phosphorylated BRCA2 130 binds to PLK1 (Fig. 3c lane 4, Fig. 3d ). In contrast, the fraction of PLK1 in the eluate of 131 BRCA2 1-250 -T207A was substantially reduced (Fig. 3c , lane 8 compared to lane 4, Fig. 3d ) 132 indicating that the phosphorylation of T207 is required for efficient binding to PLK1 and
133
confirming our results with cell lysates (Fig. 3a, b) . Strikingly, we observed no difference in 0.02 µM; Supplementary Fig. 3a ), whereas it did not bind to the corresponding non-150 phosphorylated polypeptides (Fig. 3i, Supplementary Fig. 3b ). Mutation T207A also 151 abolished the interaction (Fig. 3j ), in agreement with the pull-down experiments ( Fig. 3a-d ).
More surprisingly, the phosphomimetic substitution T207D was not sufficient to create a 153 binding site for PLK PDB ( Supplementary Fig. 2c ). A peptide comprising pT207 and the mutation S206C could not bind to PLK1 PBD (Fig. 3k) , as predicted from the consensus 155 sequence requirement for PLK1 PBD interaction 24 . Last, a peptide containing phosphorylated 156 S197, which is also a predicted docking site for PLK1, bound with much less affinity to 157 PLK1 PBD than pT207 (K d = 17 ± 2 µM; Supplementary Fig. 2d ).
158
To further characterize this molecular interaction, we determined the crystal structure of
159
PLK1 PBD bound to the T207 phosphorylated peptide at 3.1Å resolution (Supplementary table   160 2). Analysis of this 3D structure showed that, as expected, the 17 aa BRCA2 phosphopeptide 161 binds in the cleft formed between the two Polo boxes (Fig. 3l ). Twelve residues of the peptide
162
(from A199 to I210) are well-structured upon binding, burying about 694 Å 2 in the interface 163 with PLK1 PBD . BRCA2 residues from P202 to L209 are at least 25% buried in the complex.
164
The interface between BRCA2 and PLK1 PBD is stabilized by 12 hydrogen bonds: the 165 backbone of residues T200 to L209 as well as the side chain of S206 are bonded to residues 166 from Polo Box 1, whereas the side chain of phosphorylated T207 is bonded to residues from 167 Polo Box 2 (see the zoom view in Fig. 3l) K540 and R557 in Polo Box 2 (see the zoom view in Fig. 3l ). This explains the critical 175 dependence on phosphorylation for binding observed by ITC (Fig. 3h, i) . Fig. 5a ) as previously reported 4 supporting the idea that this complex takes 242 place at the kinetochore.
243
Importantly, cells expressing the variants S206C or T207A showed a strong reduction in the 244 interaction of BRCA2 with PLK1, PP2A, BUBR1 and pT680-BUBR1 in the context of the 245 tetrameric complex (Fig. 5a, b) . Moreover, the overall levels of BUBR1 and pBUBR1 were Supplementary Fig. 5d ), and this was also the case in BRCA2 deficient cells (DLD1
249
BRCA2
-/-cells) or U20S cells depleted of BRCA2 by siRNA (Fig. 5f, g ). Furthermore, we 250 observed an overall reduction in the levels of pBUBR1 at the kinetochore (Fig. 5h, i (Fig. 6c ).
280
Our results strongly suggest that docking of PLK1 onto BRCA2 T207 facilitates the 281 formation of a complex between phosphorylated BUBR1 and PP2A at the kinetochore. This is to an increased interaction of PLK1 with BUBR1 ( Supplementary Fig. 6c, d ).
285
The variants that reduce PLK1 phosphorylation of BRCA2 display strong defects in 
Discussion
398
Our results demonstrate that residues S193 and T207 of BRCA2 can be efficiently phosphorylated by PLK1 (Fig. 2) (Fig. 3h-l) . Accordingly, BRCA2 missense variants of unknown
403
clinical significance reducing the phosphorylation status of T207 (T207A, S206C) result in a 404 decreased in BRCA2-PLK1 interaction (Fig. 3a-k, 4a ). display defective chromosome congression to the metaphase plate (Fig. 5j, k) , causing a 409 substantial delay in mitosis progression (Fig. 4c-e) .
410
Proper kinetochore-microtubule attachments require the interaction of BUBR1 with the 411 phosphatase PP2A-B56α to balance Aurora B kinase activity 20, 22 . This interaction is 412 mediated through the phosphorylation of the KARD motif of BUBR1 by PLK1. BRCA2
413
does not alter PLK1 interaction with BUBR1 ( Supplementary Fig. 6c, d ). However, we found 414 that BRCA2 forms a tetrameric complex with PLK1-pBUBR1-PP2A, and that this complex is 415 strongly reduced in cells bearing BRCA2 variants S206C and T207A (Figure 5a , 5b).
416
Furthermore, cells bearing BRCA2 variants S206C and T207A show reduced overall levels of 417 BUBR1 including pBUBR1(pT680) at the kinetochore (Fig. 5i) . Importantly, the fact that in 418 the BRCA2 mutated cells the interaction of PP2A with total BUBR1 is reduced (Fig. 5c, d) 
419
and that neither this interaction (Fig. 6c) nor the chromosome alignment defect can be rescued 420 by BUBR1-3D overexpression (Fig. 6a, b ) strongly suggests that PP2A needs to be in 421 complex with PLK1-bound BRCA2 to bind BUBR1 and facilitate chromosome alignment.
Cells bearing T207A and S206C variants display chromosome segregation errors including 423 lagging chromosomes and chromosome bridges (Fig. 6d, e) . Importantly, these accumulated 424 errors ultimately lead to a broad spectrum of chromosome gains and losses (aneuploidy) 425 compared to the wild type counterpart (Fig. 7a) , but not to tetraploid cells (Fig. 7c) ,
426
suggesting that cytokinesis per se, in which BRCA2 is also involved [11] [12] [13] , is not affected.
427
Finally, the function of BRCA2-PLK1 interaction in mitosis seems to be independent of the 428 HR function of BRCA2 as cells expressing these variants display mild sensitivity to DNA 429 damage (MMC) and PARP inhibitors (Fig. 8a-c) , normal recruitment of RAD51 to DNA 430 damage sites (Fig. 8e, Supplementary Fig. 8b ), absence of micronuclei ( Supplementary Fig.   431 8d, e), rescue the chromosome bridges phenotype of BRCA2 deficient cells ( Figure 6d ) and 432 their HR activity, as measured by DSB-mediated gene targeting, is intact (Fig. 8f, 
433
Supplementary Fig. 9 ). Nevertheless, we cannot rule out that the mild phenotype observed in 434 some of these experiments in cells bearing S206C and T207A may arise from a distorted 435 interaction with an unknown DNA repair factor that would bind to the region of BRCA2
436
where these variants localize.
437
Putting our results together we reveal an unexpected chromosome stability control mechanism 438 that depends on the phosphorylation of BRCA2 by PLK1 at T207. We show that BRCA2 439 pT207 is a docking platform for PLK1 that ensures the efficient interaction of BUBR1 with
440
PP2A phosphatase required for chromosome alignment.
441
We propose the following working model ( prometaphase at the kinetochore, leading to an enrichment of phosphorylated BUBR1 and the 445 phosphatase PP2A to balance Aurora B activity (Fig. 8g, panel 1 favoring the formation of a complex between PP2A and pBUBR1.
456
Once the kinetochore-microtubule attachments are established and proper tension is achieved,
457
BUBR1 is no longer phosphorylated by PLK1 19 . This leads to a full alignment of 458 chromosomes at the metaphase plate, SAC inactivation (Fig. 8g, panel 2 ) and the subsequent 459 faithful chromosome segregation in anaphase (Fig. 8g, panel 3) .
460
In cells expressing the variants that impair T207 phosphorylation (S206C, T207A), PLK1
461 cannot be recruited to pT207-BRCA2, impairing the formation of the complex with PLK1,
462
PP2A and BUBR1 (Fig. 8g, panel 1' ), which in turn reduces the amount of pBUBR1 and its 463 binding to PP2A for proper kinetochore-microtubule interactions. This leads to chromosome 464 misalignment defects that prolong mitosis (Fig. 8g, panel 2') ; as a consequence, these cells 465 exhibit increased chromosome segregation errors (Fig. 8g, panel 3' ) and aneuploidy.
466
Although the individual BRCA2 variants analysed here are rare (Supplementary table 1 this idea, the BRCA2 deficient cells or cells transiently depleted of BRCA2 used in this study exhibit low levels of phosphorylated BUBR1 (Fig. 5f, g ). Thus, the chromosome alignment 471 function described here could be responsible, at least in part, for the numerical chromosomal 472 aberrations observed in BRCA2-associated tumors 44 .
473
Finally, the lack of sensitivity to the PARP inhibitor Olaparib observed in our cell lines ( 
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